Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OCEAN: Omacor for Carotid Plaque Stability
NCT00294216Phase 3Completed
- Sponsor
- Pronova BioPharma
- Start
- Aug 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of omega-3-acid ethyl esters in carotid artery disease, sponsored by Pronova BioPharma. Primary endpoint: Composite endpoint of structural changes associated with plaque rupture and instability. Started Aug 2003; status: completed.
02
Drugs
omega-3-acid ethyl esters
03
Conditions
carotid artery disease
Beyond the preview
Go deeper on NCT00294216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00294216.